ad

Nifty Healthcare Prediction for Monday, 27 July 2026: Apollo, Max and Fortis Levels

Nifty Healthcare prediction for Monday 27 July: Apollo Rs 8,805.50 (-0.64%). Max Rs 1,080.40. Fortis Rs 948.70 (+0.64%). Nifty Pharma 25,548.15 (-0.41%).


24 Jul 20264:45 pm

Nifty Healthcare Prediction for Monday, 27 July 2026: Apollo, Max and Fortis Levels

The Nifty Healthcare prediction for Monday, 27 July 2026, is mildly cautious near term after hospital heavyweights drifted lower on Friday: Apollo Hospitals slipped 0.64% to Rs 8,805.50 and Max Healthcare eased 0.35% to Rs 1,080.40, while Fortis Healthcare bucked the trend with a 0.64% gain to Rs 948.70. The pharma sleeve of the index also softened, with Nifty Pharma closing 0.41% lower at 25,548.15, though both healthcare wings fell less than they might have in a week this turbulent.

Ankit Jaiswal, Senior Research Analyst at Univest, leads this Nifty Healthcare prediction for Monday, with Kunal Singla, Associate Director, monitoring the defensives rotation across pharma, hospitals and diagnostics. Their read: shallow dips in quality healthcare names remain accumulation opportunities.

Click Here – Get Free Investment Predictions

Friday Data Behind the Nifty Healthcare Prediction for Monday

Stock / Index Close Day Change
Nifty Pharma 25,548.15 -0.41%
Apollo Hospitals Rs 8,805.50 -0.64%
Max Healthcare Rs 1,080.40 -0.35%
Fortis Healthcare Rs 948.70 +0.64%
Nifty 50 23,767.45 -0.43%

Healthcare fell roughly in line with the market rather than leading the decline, and Fortis closed green. That controlled behaviour keeps the Nifty Healthcare prediction for Monday closer to neutral than bearish.

Nifty Healthcare Prediction for Monday: Stock-Wise Levels

  • Apollo Hospitals: Support at Rs 8,792, Friday's low; resistance at Rs 8,870. A hold above Rs 8,800 keeps the uptrend intact.
  • Max Healthcare: Support at Rs 1,068, resistance at Rs 1,086; the stock is coiling in a narrow band awaiting Q1 numbers.
  • Fortis Healthcare: Friday's leader; support at Rs 928 and resistance at Rs 951, with a close above Rs 951 extending momentum.
  • Pharma anchor: Nifty Pharma support at 25,458 and resistance at 25,687 frame the medicine half of the healthcare index.

Ankit Jaiswal observes that hospital operators carry pricing power and occupancy visibility that few sectors can match in a volatile macro, while export-facing pharma quietly benefits from the rupee near 96.66 per dollar. He has flagged Fortis for continuation and Apollo for a buy-the-dip setup near Rs 8,800.

Compare hospital and pharma stocks on the Univest Screener

Drivers Behind the Nifty Healthcare Prediction for Monday

  • Defensive appeal: With India VIX up 4.08% to 14.03, healthcare's earnings stability attracts risk-averse flows.
  • Weak rupee benefit: Formulation exporters earn in dollars, so currency weakness cushions pharma margins.
  • Q1 season: Hospital occupancy trends and pharma US pricing commentary through early August are the next stock-specific catalysts.
  • Broader recovery: The Sensex closed at 76,059.77 after erasing most of a 900-point fall, and Bank Nifty ended positive at 56,693.50; a stabilising tape lets healthcare grind higher without hurry.

Positioning Around the Nifty Healthcare Prediction for Monday

Staggered accumulation suits this setup better than chasing. Investors balancing a portfolio can hold healthcare alongside large financials such as HDFC Bank and ICICI Bank, both steady on Friday, and index heavyweight Reliance Industries, up 0.46%, to blend defence with recovery exposure.

Download the Univest iOS App or Univest Android App to track healthcare stocks and Q1 result dates live.

Conclusion

The Nifty Healthcare prediction for Monday, 27 July 2026, is neutral to mildly positive: Friday's drift was orderly, Fortis is leading, and Apollo near Rs 8,800 offers the cleanest accumulation zone. Ankit Jaiswal and Kunal Singla expect defensive flows to persist while volatility stays elevated, with Q1 results as the next catalyst. Consult a SEBI-registered advisor before investing.

Disclaimer

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the Nifty Healthcare prediction for Monday, 27 July 2026?

Ans. The Nifty Healthcare prediction for Monday is neutral to mildly positive. Apollo Hospitals closed at Rs 8,805.50, Max Healthcare at Rs 1,080.40 and Fortis gained 0.64% to Rs 948.70, with the sector falling less than the broader market.

Which healthcare stock showed the most strength before Monday?

Ans. Fortis Healthcare was Friday's leader, rising 0.64% to Rs 948.70 against a falling market. A close above Rs 951 would extend its momentum into the new week.

What are the Apollo Hospitals levels for Monday?

Ans. Apollo has support at Rs 8,792, Friday's low, and resistance at Rs 8,870. The zone near Rs 8,800 is flagged as an accumulation area in the Nifty Healthcare prediction for Monday.

Why is healthcare considered defensive on Monday?

Ans. Hospital revenues and medicine demand stay stable regardless of crude prices or geopolitical headlines, so the sector attracts flows when India VIX rises, as it did with a 4.08% jump on Friday.

Which analysts prepared this Nifty Healthcare prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, leads the Nifty Healthcare prediction for Monday, 27 July 2026, with Kunal Singla, Associate Director, tracking the defensive rotation.

How does the weak rupee help healthcare stocks on Monday?

Ans. Pharma exporters within the healthcare index earn in dollars, so the rupee near 96.66 per dollar improves their realisations and cushions margins even when domestic sentiment is weak.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down